Selexis empowers scientists and biopharmaceutical companies around the world to realize the full potential of their work.

Who we are

Selexis SA is the global leader in mammalian cell line development, providing the highly specialized technology and expertise that are needed to translate scientific innovation into life-saving medicines.

SUREtechnology Platform

With more than 100 partners worldwide, 95+ drug products in clinical development and three commercial products utilizing Selexis-generated cell lines, the Company has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research.

LOREM IPSUM

RECENT AND UPCOMING EVENTS

April 18-20, 2018
BioPh/CPhI, Tokyo Japan

April 23 – 25, 2018
Cell Line Development & Engineerng, Amsterdam, Netherlands

April 30 – May 4, 2018
PEGS Summit, Boston, USA

May 9-11, 2018
BioKorea, Seoul, Korea

June 4 – 7, 2018
BIO International Convention, Boston, USA

June 27-29, 2018
BioPharma Expo Japan, Tokyo, Japan

 



We are Social